Infographic. Coverage of opioid agonist treatment in 2021 or the most recent year and in the previous estimate
Publication date
Description
This resource is part of the European Drug Report 2023, the EMCDDA's annual overview of the drug situation in Europe.
Coverage is defined as the share of high-risk opioid users receiving the intervention. Data are displayed as point estimates and uncertainty intervals.
Source data
The data used to generate infographics and charts on this page may be found below.
List of tables
- Table 1 (Coverage of opioid agonist treatment in 2021 or the most recent year and 2011/12)
- Table 2a (Clients in opioid agonist treatment)
- Table 2b (Trends in the number in opioid agonist treatment)
- Table 3 (Number of European countries implementing opioid agonist treatment, up to 2022)
Year | Series | Country | Low | Estimate | High |
---|---|---|---|---|---|
2017 | 2021 or most recent | Latvia | 8 | 10 | 12 |
2020 | 2021 or most recent | Romania | 8 | 10 | 13 |
2016 | 2021 or most recent | Lithuania | 9 | 15 | 21 |
2021 | 2021 or most recent | Cyprus | 10 | 17 | 25 |
2014 | 2021 or most recent | Poland | 16 | 21 | 28 |
2021 | 2021 or most recent | Slovakia | 14 | 23 | 32 |
2016 | 2021 or most recent | Denmark | 16 | 27 | 39 |
2016 | 2021 or most recent | Germany | 48 | 49 | 49 |
2015 | 2021 or most recent | Croatia | 39 | 50 | 62 |
2021 | 2021 or most recent | Austria | 50 | 52 | 54 |
2019 | 2021 or most recent | Ireland | 49 | 53 | 54 |
2021 | 2021 or most recent | Czechia | 57 | 59 | 61 |
2018 | 2021 or most recent | Portugal | 42 | 64 | 98 |
2019 | 2021 or most recent | Belgium | 72 | ||
2021 | 2021 or most recent | Slovenia | 69 | 75 | 80 |
2020 | 2021 or most recent | France | 78 | 80 | 82 |
2021 | 2021 or most recent | Greece | 56 | 85 | 100 |
2013 | 2021 or most recent | Norway | 56 | 86 | 100 |
2019 | 2021 or most recent | Luxembourg | 86 | ||
2020 | 2021 or most recent | Malta | 77 | 89 | 95 |
2020 | 2021 or most recent | Spain | 65 | 90 | 100 |
2012 | Previous estimate | Latvia | 4 | 5 | 7 |
2016 | Previous estimate | Romania | 5 | 7 | 9 |
2007 | Previous estimate | Lithuania | 7 | 7 | 7 |
2011 | Previous estimate | Cyprus | 25 | 31 | 37 |
2009 | Previous estimate | Poland | 10 | 13 | 19 |
2018 | Previous estimate | Slovakia | 11 | 20 | 28 |
Previous estimate | |||||
Previous estimate | |||||
Previous estimate | |||||
2011 | Previous estimate | Austria | 54 | 55 | 57 |
2011 | Previous estimate | Ireland | 44 | 53 | 57 |
2011 | Previous estimate | Czechia | 46 | 48 | 51 |
2012 | Previous estimate | Portugal | 66 | 75 | 88 |
Previous estimate | |||||
Previous estimate | |||||
Previous estimate | |||||
2011 | Previous estimate | Greece | 30 | 33 | 37 |
Previous estimate | |||||
Previous estimate | |||||
Previous estimate | |||||
2010 | Previous estimate | Spain | 82 | 96 | 100 |
Characteristic | Number in treatment | Data | Unit |
---|---|---|---|
Number in treatment | EU | 511210 | number |
Number in treatment | EU+2 | 523821 | number |
Age | <15 | 0 | % |
Age | 15-19 | 0 | % |
Age | 20-24 | 2 | % |
Age | 25-29 | 5 | % |
Age | 30-34 | 11 | % |
Age | 35-39 | 17 | % |
Age | 40-44 | 20 | % |
Age | 45-49 | 16 | % |
Age | 50-54 | 15 | % |
Age | 55-59 | 7 | % |
Age | 60-64 | 5 | % |
Age | >64 | 1 | % |
Gender | Females | 23 | % |
Gender | Males | 77 | % |
Medication | Methadone | 55.88 | % |
Medication | Buprenorphine | 34.57 | % |
Medication | Other | 6.73 | % |
Medication | Slow-release oral morphine | 2.56 | % |
Medication | Diacetylmorphine | 0.24 | % |
Medication | Dihydrocodeine | 0.02 | % |
Duration | <12 | 10 | % |
Duration | 12 to 24 | 11 | % |
Duration | 25 to 60 | 27 | % |
Duration | 61 to 120 | 21 | % |
Duration | >120 | 30 | % |
Country | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Spain | 82372 | 76263 | 69111 | 61954 | 61859 | 59264 | 58749 | 58857 | 58447 | 58540 | 55058 | 55058 |
Germany | 77400 | 76200 | 75400 | 77300 | 77500 | 77200 | 78500 | 78800 | 79400 | 79700 | 81300 | 81300 |
Other countries | 110244 | 113180 | 111533 | 104996 | 106186 | 106951 | 106194 | 107576 | 108587 | 109814 | 110117 | 111228 |
France | 155944 | 170322 | 172795 | 176065 | 174274 | 178313 | 178560 | 177490 | 177100 | 178700 | 178800 | 180000 |
Year | Buprenorphine/naloxone combination | Heroin assisted treatment (including pilots) | High-dosage buprenorphine treatment | Methadone maintenance treatment | Opioid agonist treatment in prison | Slow-release morphine |
---|---|---|---|---|---|---|
1967 | 1 | |||||
1968 | 2 | |||||
1969 | ||||||
1970 | 3 | |||||
1971 | ||||||
1972 | ||||||
1973 | ||||||
1974 | 4 | |||||
1975 | 5 | |||||
1976 | ||||||
1977 | 6 | |||||
1978 | ||||||
1979 | ||||||
1980 | ||||||
1981 | ||||||
1982 | ||||||
1983 | ||||||
1984 | ||||||
1985 | 1 | |||||
1986 | ||||||
1987 | 8 | 2 | ||||
1988 | 3 | |||||
1989 | 9 | |||||
1990 | 11 | 4 | ||||
1991 | 12 | |||||
1992 | 15 | 6 | ||||
1993 | 16 | |||||
1994 | 17 | |||||
1995 | 20 | 9 | ||||
1996 | 1 | 22 | ||||
1997 | 2 | 23 | ||||
1998 | 1 | 3 | 26 | 10 | 1 | |
1999 | 8 | 11 | ||||
2000 | 10 | 14 | ||||
2001 | 11 | 27 | 15 | |||
2002 | 14 | |||||
2003 | 3 | 15 | ||||
2004 | 1 | 16 | 16 | |||
2005 | 18 | 3 | ||||
2006 | 4 | 19 | 19 | 5 | ||
2007 | 7 | 20 | ||||
2008 | 13 | 4 | 23 | |||
2009 | 16 | |||||
2010 | 24 | |||||
2011 | 5 | |||||
2012 | 17 | 25 | ||||
2013 | ||||||
2014 | 26 | |||||
2015 | ||||||
2016 | ||||||
2017 | ||||||
2018 | ||||||
2019 | 18 | |||||
2020 | ||||||
2021 | ||||||
2022 | 18 | 5 | 20 | 27 | 26 | 5 |
Hidden tables for page
ID | Term |
---|---|
10 | WHO target |
20 | Recent/penultimate |
30 | Number in treatment |
40 | Gender breakdown (percent) |
50 | Trends in the number in opioid agonist treatment |
60 | Age distribution |
70 | Type of medication |
80 | Treatment duration (months) |
90 | Number of countries |
Originally published in
European Drug Report 2023: Trends and Developments
Main subject
Target audience
Type
Copyright status
- Creative Commons Attribution 4.0 International (CC BY 4.0)
Related assets in the Media library
Previous slide
Next slide